Moore, A. S., Alonzo, T. A., Gerbing, R. B., Lange, B. J., Heerema, N. A., Franklin, J., . . . Meshinchi, S. (2013). BIRC5 (Survivin) Splice Variant Expression Correlates With Refractory Disease and Poor Outcome in Pediatric Acute Myeloid Leukemia: A Report From the Children's Oncology Group. Pediatr Blood Cancer.
Citação norma ChicagoMoore, Andrew S., et al. "BIRC5 (Survivin) Splice Variant Expression Correlates With Refractory Disease and Poor Outcome in Pediatric Acute Myeloid Leukemia: A Report From the Children's Oncology Group." Pediatr Blood Cancer 2013.
Citação norma MLAMoore, Andrew S., et al. "BIRC5 (Survivin) Splice Variant Expression Correlates With Refractory Disease and Poor Outcome in Pediatric Acute Myeloid Leukemia: A Report From the Children's Oncology Group." Pediatr Blood Cancer 2013.